Edit
MedaSystems Expanded Access Software
http://www.medasystems.com/Last activity: 05.03.2025
Active
Streamline patient and provider inquiries for Expanded Access or Compassionate Use with secure, 21st Century Cures Act compliant, cloud software.
Location: United States, California, Menlo Park
Total raised: $1.5M
Founders name: John Langlands
Funding Rounds 1
| Date | Series | Amount | Investors |
| 23.03.2022 | Pre-Seed | $1.5M | Nina Capit... |
Persons 4
| Date | First Name | Last Name | Title | Location | |||
| - | Brendan | Riley | Chief Reve... | linkedin.c... | - | B*****n@me... | - |
| - | Fiona | Smythe | Chief Exec... | linkedin.c... | - | f***a@meda... | - |
| - | Samik | Mukherjee | VP of Engi... | linkedin.c... | - | s***k@meda... | - |
| - | John | Langlands | Co-Founder... | linkedin.c... | - | j**n@medas... | - |
Mentions in press and media 7
| Date | Title | Description |
| 07.03.2025 | MedaSystems: Pioneering the Future of Expanded Access with AI-Driven Solutions | In the heart of Silicon Valley, MedaSystems is making waves. This Menlo Park-based company is not just another tech startup; it’s a lifeline for patients in desperate need of experimental therapies. Recently, MedaSystems secured additional ... |
| 05.03.2025 | MedaSystems Secures Additional Seed Financing to Advance Its AI-Driven Workflow Platform for Expanded Access and Investigator-Initiated Studies | MENLO PARK, Calif.–(BUSINESS WIRE)–March 5, 2025– MedaSystems, the leading SaaS platform for Expanded Access (EA) and Investigator-Initiated Studies (IIS), today announced additional funding from existing investors, Debiopharm Innovation Fu... |
| 05.03.2025 | MedaSystems Raises Additional Seed Financing | MedaSystems, a Menlo Park, CA-based provider of a SaaS platform for expanded access (EA) and investigator-initiated studies (IIS), raised an additional undisclosed amount in Seed funding. Backers included Debiopharm Innovation Fund, Nina Ca... |
| 09.01.2024 | MedaSystems Receives Additional Funding | MedaSystems, a Menlo Park, CA-based provider of software for access to pre-approval medicine, received additional funding from Debiopharm Innovation Fund. The amount of the deal was not disclosed. Led by Fiona Smythe, MedaSystems is a devel... |
| 12.10.2023 | MedaSystems Raises Seed Financing | MedaSystems, a Menlo Park, CA-based developer of a purpose-built pharma-physician network, raised an undisclosed amount in Seed funding. Participants included Young Sohn, a founder of Veeva Systems, Vlocity, and Nomadic Systems; nina.capita... |
| 23.03.2022 | MedaSystems Raises $1.5M in Pre-Seed Funding | MedaSystems Expanded Access platform connects physicians and pharmaceutical manufacturers to help patients gain access to investigational therapies. MedaSystems, a Menlo Park, Calif.-based digital health software company, raised $1.5m in pr... |
| 15.03.2022 | MedaSystems announces $1.5M pre-seed round led by Nina Capital, and also followed up by a group of angel investors | 15/03/2022 Press release MEDASYSTEMS ANNOUNCES PRE-SEED FUNDING RAISE. We’re excited to share that we’ve closed a pre-seed funding round! We’re providing text of the full press release here. Menlo Park, California — MedaSystems, a digit... |